Share the article


Antibiotic Shortages: magnitude, causes and possible solutions: A new WHO meeting report

Unavailability and shortages of antibiotics is an increasing problem for many countries with consequences both for patient safety and societal cost. At a WHO meeting end 2018, a project funded by ReAct through Sida, the magnitude, causes and possible solutions of antibiotic shortages were discussed.


ReAct’s new 5-year strategic plan receives funding from Sida

ReAct will align its work to respond to the next challenge: to ensure that the long-awaited response is corresponding to meet the actual needs, in particular in low- and middle-income countries. To address this new situation, ReAct will focus on four strategic areas in the coming five years, this with continued core funding from Sida.


Antibiotic resistance and global development: alarming rates in armed conflicts

Antibiotic resistance is a major obstacle for achieving the Sustainable Development Goals. In ReAct’s report “When the Drugs Don’t Work – Antibiotic Resistance as a Global Development Problem’”, we have identified the vulnerability of populations in conflict and refugees to antibiotic resistance. People affected by conflict should not be overlooked, but be seen as an especially vulnerable group in the global response to antibiotic resistance.


How infections spread and how to stop them

Infectious diseases are different from other diseases in that they are caused by microorganisms that spread from one individual to another, sometimes passing through other humans, animals, or an environmental reservoir. While infectious diseases spread wherever and whenever they are able to, several situations increase the risk that infections as well as antibiotic resistance spread. To understand why and how some people are more vulnerable, we need to understand how infections are transmitted.


New ReAct Report: When the Drugs Don’t Work - Antibiotic Resistance as a Global Development Problem

This new report by ReAct and Dag Hammarskjöld Foundation looks at the state of global development when the drugs don’t work and a post-antibiotic era sets in. The report shows how antibiotic resistance is a global development problem by highlighting existing data and people’s experiences.


7 high-level standpoints from ReAct on the IACG draft recommendations

The IACG on AMR released the draft recommendations for public discussion from 29 January to 19 February. This marks the final round of stakeholder input collection before the recommendations are finalized for submission to the UN Secretary General by April 2019. The process towards the UN General Assembly will greatly determine the strategic directions of global response to antimicrobial resistance.

ReAct has developed our main opinions on the draft recommendations.


Generating data for policy and practice

Knowledge is critical for good policy and practical work. In the Global Action Plan on AMR adopted by WHO in 2015, strategic objective 2 is to “Strengthen the knowledge and evidence base through surveillance and research”. But how can this be done in countries that lack funds and technical capacity?


New platform for setting the African research agenda

In the African region surveillance and laboratory data is sparse and there is concern that the National Action Plans on AMR are not founded on a strong evidence-base detailing the specifics of the problem nor on interventions proven to be effective in African contexts. This is why ReAct Africa hosted a research priority setting workshop end 2018.


Three political actions needed on antimicrobial resistance in 2019

The WHO has identified antimicrobial resistance as a top ten priority global health threat for 2019. Three years after the Political Declaration on AMR was adopted by all Member States in 2016, we are now at a critical point in time to shape the world’s response to the issue. For 2019, political action must be stepped up. We urge countries to take up the work on antimicrobial resistance as a top priority, and would like to see the following happen…


Outbreak of extremely drug resistant typhoid fever in Pakistan

Since November 2016, Pakistan has been plagued by an outbreak of extremely resistant typhoid fever. What is so special with this outbreak, and are there broader lessons to be learned from it?

ReAct Interview

Growing public response to AMR in Thailand

Thailand has very impressive health indicators and is among the few countries in the South-East Asia region that boasts of a Universal Health Care system. Despite these achievements, antimicrobial resistance has been a growing problem in Thailand. Dr Niyada Kiatying-Angsulee, Thailand’s foremost civil society activist on antimicrobial resistance, speaks to ReAct about the growing public awareness issues related to antimicrobial resistance in Thailand.


Pharmacologists' involvement will add new dimension

After the launch of the Kerala Antimicrobial Resistance Strategic Action Plan, ReAct Asia Pacific was asked to arrange a workshop for pharmacologists. One of the main purposes of this program was to initiate and strengthen the role of pharmacologists within the antibiotic stewardship team in tertiary care teaching hospitals.


Antibiotic footprint: change the way food is labelled?

As consumers around the globe become more aware of the dangers of antimicrobial resistance meat producers and food retailers everywhere are rushing to label their products as “antibiotic-free” or as “raised without antibiotics”. The trouble is though, these labels do not fully explain in accurate terms what exactly they mean.